Company: GMRE
Filing Date: 2025-11-13
Form Type: 424B5
Source: 0001104659-25-110926
Chunk: 26

Company: Global Medical REIT Inc.
Filing Date: 2025-11-13
Form: 424B5
Chunk 26
---
 and will not be subject to any sinking fund or mandatory redemption, and will remain outstanding indefinitely unless and until
(i) we redeem such Series B Preferred Stock at our option as described below in “— Redemption,” or (ii) they
are converted by the holder of such Series B Preferred Stock in the event of a Change of Control as described below in “—
Conversion Right upon a Change of Control.”

Ranking

The Series B Preferred Stock will rank, with
respect to dividend rights and rights upon our liquidation, dissolution or winding up:

| 1) | senior to our common stock and to any other class or series of our equity shares the terms of which provide that such equity securities   
 rank junior to the Series B Preferred Stock with respect to rights of dividend payments and the distribution of assets upon any voluntary 
 or involuntary liquidation, dissolution or winding up of the Company (“junior equity shares”);                                            |

| 2) | on parity with our Series A Preferred Stock and any other preferred or convertible preferred stock of the Company, the terms 
 of which provide for cumulative dividends, other than the securities referred to in clauses (1) and (3) (“parity equity      
 shares”); and                                                                                                                |

| 3) | junior to all equity shares issued by us with terms specifically providing that those equity shares rank senior to the Series B              
 Preferred Stock with respect to rights of dividend payments and the distribution of assets upon any voluntary or involuntary liquidation,    
 dissolution or winding up of the Company, which issuance is subject to the approval of the holders of two-thirds of the outstanding Series B 
 Preferred Stock and any parity equity shares.                                                                                                |

<div align='center'>S-15</div>

The term “equity shares” does not
include convertible debt securities, which debt securities would rank senior to the Series B Preferred Stock.

Dividends

Holders of Series B Preferred Stock will
be entitled to receive, when, as and if declared by our Board of Directors or a duly authorized committee of the Board of Directors, out
of funds legally available for the payment of dividends under Maryland law, cumulative cash dividends from the original issue date or
the immediately preceding dividend payment date, as applicable, quarterly in arrears on January 31, April 30, July 31 and
October 31 of each year (each, a “dividend payment date”). The first dividend is scheduled to be paid on January 31,
2026 to holders of record as of January 15, 202